Retinoids
Retinoids, the natural and synthetic derivatives of vitamin A, are a gold-standard class of active ingredients with the strongest clinical evidence base in modern dermatology. They act directly on keratinocyte differentiation, regulate sebum production, reduce inflammation and remodel the collagen network in the dermis. Because they bind precisely to receptors in the cell nucleus, retinoids are used across a wide range of conditions, from acne vulgaris and psoriasis to disorders of keratinization (ichthyosis) and the repair of photoaging.
At Haute-Derma, retinoid therapy, both topical and oral, is managed with individually tailored strengths, careful control of irritation and purging, protection of the skin barrier and monitoring for systemic toxicity in line with international standards.
Mechanism of Action and RAR/RXR Nuclear Receptor Pharmacology
Signaling Through Nuclear Receptors
Retinoids diffuse freely across the cell membrane, bind to cytoplasmic transport proteins (CRABP) and move into the nucleus. There they bind to two main families of nuclear receptors:
- RAR (retinoic acid receptors): Three isoforms, RAR-alpha, RAR-beta and RAR-gamma; RAR-gamma accounts for more than 87% of all RAR in skin keratinocytes.
- RXR (retinoid X receptors): RXR-alpha, RXR-beta and RXR-gamma.
The RAR-RXR heterodimer binds to specific DNA sequences called retinoic acid response elements (RAREs). This regulates gene transcription: it suppresses genes that drive excessive keratinization, dampens the nuclear factors AP-1 and NF-kappaB (preventing collagen breakdown by MMP enzymes) and stimulates production of type I and type III collagen.
Key Biological Effects on the Skin
- Reduced keratinocyte cohesion and comedone clearance (comedolytic effect): Retinoids loosen keratinocytes in the follicular opening, prevent microcomedones from forming and speed up epidermal cell turnover.
- Sebum suppression: Oral isotretinoin shrinks sebocytes by triggering apoptosis (programmed cell death), reducing sebum output by up to 80–90%.
- Dermal regeneration and anti-aging: Fibroblasts are stimulated to make more collagen, elastin and glycosaminoglycans (the skin's own hyaluronic acid), thickening the dermis and smoothing the skin surface.
Generations of Retinoids in Clinical Use
- First generation (natural / non-selective): Bind non-selectively to both RAR and RXR. Highly effective, but with high rates of skin irritation (topical) and systemic toxicity (oral).
- Second generation (monoaromatic): Modified benzene-ring structure. Mainly used orally for chronic psoriasis and genetic disorders of keratinization.
- Third generation (polyaromatic): Molecules that bind selectively to RAR-beta and RAR-gamma. Less irritating than the first generation and more photostable.
- Fourth generation (trifarotene): The newest derivative, highly selective for RAR-gamma, optimized for treating widespread acne on the chest and back at very low concentrations.
Pharmacological Comparison of Common Retinoids
| Active Ingredient (Generic) | Generation and Route | Skin Irritation / Toxicity |
|---|---|---|
| Tretinoin (0.025%–0.1%) | First generation (topical) | Very high (photosensitivity, peeling) |
| Adapalene (0.1%–0.3%) | Third generation (topical) | Low to moderate (cosmetically elegant, photostable) |
| Tazarotene (0.05%–0.1%) | Third generation (topical) | High (redness, marked stinging) |
| Isotretinoin (10–20 mg) | First generation (oral) | Severely teratogenic; dry mucous membranes |
| Acitretin (10–25 mg) | Second generation (oral) | Long-lasting teratogenicity (stored in fat tissue) |
Managing Purging, Irritation and Systemic Toxicity
Retinoid Purging vs. Irritation or Allergic Flare
- Retinoid purging (an expected reaction): Faster cell turnover brings hidden microcomedones to the surface sooner. Breakouts appear in your usual acne areas, run a quick course (pustules dry up fast) and settle on their own within 4–8 weeks.
- Irritation or allergic flare: Red bumps and tiny pustules appear even in areas that never break out, with intense redness, itching or burning, cracking and persistent transepidermal water loss (TEWL) that does not settle.
Controlling the Toxicity of Oral Isotretinoin and Acitretin
- Teratogenicity: Isotretinoin causes severe birth defects of the nervous system, heart and craniofacial structures. Two methods of contraception must be used together from 1 month before starting, throughout treatment and for 1 month after stopping isotretinoin.
- Special note on acitretin: Because it can be converted to etretinate, which is stored in fat tissue, women must strictly avoid pregnancy for 3 years after stopping acitretin.
- Metabolic toxicity: Raised blood triglycerides and cholesterol, elevated liver enzymes (AST/ALT), dry eyes, cheilitis and peeling of the palms and soles.
Treatment Protocols at Haute-Derma
Starting a Topical Retinoid (Gradual Escalation)
- Buffer method ("sandwich" technique): Apply a ceramide/B5 repair cream first → then the retinoid → then another layer of moisturizer on top. This significantly reduces the risk of irritation.
- Gradually increasing frequency: Twice a week for the first 2 weeks → every other night for the next 2 weeks → every night once the skin has adjusted.
Monitored Oral Isotretinoin Protocol
- Target cumulative dose: 120–150 mg/kg body weight (or a prolonged low-dose regimen of 0.2–0.4 mg/kg/day to minimize side effects).
- Required tests: complete blood count, AST/ALT, triglycerides, cholesterol and a pregnancy test (beta-hCG) before treatment, after 1 month and then every 2–3 months.
Recovery and Cosmetic Support at Haute-Derma
- Bio-Light therapy (blue light to target A. acnes bacteria plus soothing yellow light) to help reduce purging.
- Hyaluronic acid mesotherapy micro-injections combined with panthenol (B5) to deeply hydrate and quickly repair a skin barrier damaged by retinoids.
